Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies
The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...
मुख्य लेखकों: | Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, Fatima O. Alsamani |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
Elsevier
2022-01-01
|
श्रृंखला: | Informatics in Medicine Unlocked |
विषय: | |
ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S2352914822000247 |
समान संसाधन
-
Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
द्वारा: Abdulrahim A. Alzain, PhD, और अन्य
प्रकाशित: (2021-01-01) -
Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies
द्वारा: Fatima A. Elbadwi, और अन्य
प्रकाशित: (2021-01-01) -
Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
द्वारा: Mushtaq Hussain, और अन्य
प्रकाशित: (2020-09-01) -
Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
द्वारा: Ismail Hdoufane, और अन्य
प्रकाशित: (2025-01-01) -
Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19
द्वारा: Sergio Vazquez-Rodriguez, और अन्य
प्रकाशित: (2023-01-01)